FOLH1 and neoplasm: Both the targeted nanocarriers [89Zr]PEG-(DFB)3(ACUPA)1 and [89Zr]PEG-(DFB)1(ACUPA)3 demonstrated remarkably high PSMA-targeted uptakein PC3-Pip tumors as compared to the nontargeted [89Zr]PEG-(DFB)4, which showed only tumor peripheral accumulation irrespectiveof the tumor type.